Secondaries

Growth equity assets are seeing ‘pretty good’ bargains, yet the mismatch in valuation expectations may hinder dealmaking.

GP-led market could grow to as much as $500bn ‘effortlessly’, AltamarCAM chief executive José Luis Molina tells Secondaries Investor.

Private equity secondaries will be a $500bn market by 2030, the firm’s founder and chief investment officer Jeremy Coller tells Secondaries Investor.

The European buyout firm moved Sunrise Medical into a landmark €2.5bn multi-asset continuation vehicle six years ago.

Crown Secondaries Special Opportunities III has closed on $3bn ahead of its $2.5bn target.

Predecessor vehicle Fund IV is over 75% invested and has a TVPI of 1.5x, according to documents prepared for a US state investor.

Amid the broadening supply of private wealth-focused evergreen vehicles, ICG and Dawson Partners are the latest managers to join the fold with funds focused on secondaries.

Strategic Equity V is already larger than its $5.3bn predecessor, according to chief investment officer and chief executive Beno​ît Durteste.

Hamilton Lane Secondary Fund VI is currently sized at ‘over $5bn’, according to co-CEO Erik Hirsch.

Michael Camacho, a former long-time AlpInvest Partners executive who has worked in North America, Europe and Asia, is understood to be leaving this week.